• No results found

CHAPTER  2:   Materials and Methods 42

2.1   Cell Culture and Virological Methods 42

2.1.1

Cell  maintenance  

 

Human  cervical  (HeLa),  human  embryonic  rhabdomyosarcoma  (RD),  human  embryonic  kidney   (HEK293T),  and  murine  fibroblast  (L929)  cells  were  grown  as  monolayers  in  Dulbecco’s   Modified  Eagle’s  Medium  (DMEM)  supplemented  with  100  μg/ml  of  streptomycin,  100  U/ml  of   penicillin,  2  mM  L-­‐glutamine,  and  10%  heat  inactivated  (HI)-­‐foetal  bovine  serum  (FBS).  Baby   hamster  kidney  cells  stably  transfected  with  a  T7  RNA  polymerase  expression  plasmid  (BsrT7)   were  maintained  in  Glasgow  Minimum  Essential  Medium  (GMEM)  supplemented  with  100   μg/ml  of  streptomycin,  100  U/ml  of  penicillin,  2  mM  L-­‐glutamine,  and  10%  HI-­‐FBS.  Antibiotic   G418  was  also  added  to  BsrT7  cell  medium  to  select  cells  containing  the  T7  RNA  polymerase   gene  under  control  of  the  cytomegalovirus  (CMV)  promoter  and  the  neomycin  resistance  gene   (Buchholz  et  al.,  1999).  All  cells  were  passaged  using  trypsin-­‐  ethylenediaminetetracetic  acid   (EDTA).  

2.1.2

RNA  transfection  of  mammalian  cell  lines  

 

Purified  RNA  (amounts  as  specified  elsewhere)  in  H2O  was  made  up  to  100  μl  in  serum  and  

antibiotic  free  medium  and  mixed  with  an  equal  volume  solution  of  Lipofectamine  2000  (3:1   Lipofectamine  2000  to  μg  RNA),  (Invitrogen)  in  similar  medium.  The  mixture  was  incubated   according  to  the  manufacturer’s  instructions  and  added  to  cell  monolayers  in  either  6  or  12-­‐well   tissue  culture  plates.  

2.1.3

Luciferase  assay  

 

Supernatant  was  removed  from  transfected  cell  monolayers,  cells  were  briefly  washed  with  PBS   and  lysed  using  200  μl  1  x  Glo  Lysis  Buffer  (Promega®)  per  well  in  a  12-­‐  well  plate.  The  

oxidation  reaction  wascatalysed  by  the  addition  of  50  μl  cell  lysate  (luciferase  enzyme)  to  50  μl   room  temperature  Bright-­‐GloTM  Luciferase  Assay  System  (Promega®)  substrate  and  shielded  

Biosystems)  with  values  normalised  to  mock  transfection  controls.  

2.1.4

Isolation  of  media  from  transfected  cells  

 

Media  from  individually  or  co-­‐transfected  cells  was  isolated  at  48-­‐72  hrs  post  transfection.  Any   cellular  debris  was  pelleted  by  centrifugation,  with  media  being  placed  into  new  1.5  ml  

microfuge  tubes.  Plaque  assays  were  then  carried  out  to  detect  virus.  

2.1.5

Tissue  culture  infectious  dose50  (TCID50)  

 

Recombinant  virus  from  co-­‐transfections  was  titred  by  TCID50  which  measures  the  quantity  of  

virus  required  to  infect  50%  of  inoculated  microplate  wells  per  sample  (Minor,  1985).  Each  well   of  96-­‐well  plates  was  seeded  with  2.5  x  104  HeLa  cells,  allowing  for  four  replicates  of  titration  

per  sample.  In  a  separate  96-­‐well  round-­‐bottomed  plate,  a  serial  10-­‐fold  dilution  of  sample  with   DMEM/10%  FBS/penicillin-­‐  streptomycin  (PS)  from  10-­‐1  to  10-­‐12  was  performed.  Media  was  

removed  from  confluent  cells,  100  μl  of  the  appropriate  virus  dilution  was  added  to  each  well,   (including  100  μl  DMEM/10%  FBS/PS  to  control  wells)  and  incubated  for  1  hour  at  37°C/5%   CO2.  An  extra  100  μl  DMEM/10%  FBS/PS  was  added  per  well  and  plates  were  incubated  for  four  

days.  Plates  were  stained  with  crystal  violet  for  one  hour  and  rinsed  with  tap  water  before   drying  upside  down  on  paper  towel. Virus  titre  was  expressed  as  log10  TCID50/ml  (Reed  &  

Muench,  1938).  

2.1.6

Plaque  assay  

 

RD  or  HeLa  cells  were  seeded  in  6  or  12-­‐well  plates  and  grown  to  95%  confluency.  Where   appropriate  ten-­‐fold  dilutions  of  virus  stock  were  made  in  DMEM.  Once  medium  was  removed   from  seeded  wells,  cells  were  washed  with  sterile  PBS  then  inoculated  with  500  μl  of  prepared   virus  and  incubated  for  30  mins  at  37°C  in  the  presence  of  5%  CO2/air  to  allow  absorption  to  

occur.  Plaque  overlay  media  (refer  to  section  2.6  for  contents)  was  added  to  each  well  and   plates  were  incubated  inverted  for  two  to  three  days  at  37°C  in  the  presence  of  5%  CO2/air.  

Cells  were  stained  with  crystal  violet  solution  and  re-­‐stained  post-­‐removal  of  the  plaque  overlay   media.  Plaques  were  counted  and  the  virus  titre  expressed  as  plaque  forming  units  per  millilitre   (PFU/ml).  

2.1.7

Plaque  purification  by  limiting  dilution  

 

Recombinant  virus  from  RNA  transfections  was  biologically  cloned  by  limiting  dilution  in  96-­‐ well  microtitre  plates.  Virus  dilutions  were  performed  using  a  multichannel  pipette  in  a  round   bottomed  96-­‐well  microtitre  plate  (Sterilin)  prior  to  transfer  onto  fresh  cell  monolayers.  Fifty-­‐ five  microlitres  of  serum-­‐free  media  was  added  to  each  well  prior  to  addition  of  diluted  virus.   Approximately  55  μl  diluted  virus  supernatant  was  added  to  each  well  in  the  top  row.  After   mixing  by  pipetting,  55  μl  of  solution  was  transferred  to  the  next  row  (already  containing  55  μl   serum-­‐  free  media).  Pipette  tips  were  discarded  after  the  mixture  was  mixed  in  each  row  and   these  two-­‐fold  dilutions  continued  down  the  plate.  Fifty  microlitres  was  transferred  from  each   well  onto  a  fresh  cell  monolayer  in  flat  bottomed  96-­‐well  plates  seeded  with  2.6  x  104  HeLa  

cells/well.  The  plates  were  left  to  allow  for  virus  absorption  for  30  mins  at  37°C  in  the  presence   of  5%  CO2/air.  An  extra  200  μl  serum-­‐free  media  was  added  to  each  well  and  plates  were  

incubated  at  37°C/5%  CO2/air.  After  4  days,  the  supernatant  was  transferred  to  a  new  

microtitre  plate  and  cell  monolayers  were  stained  by  crystal  violet  for  the  presence  of  complete   CPE.  RNA  was  extracted  from  the  highest  dilution  of  virus  supernatant  per  column  and  RT-­‐PCR   was  carried  out  to  amplify  the  crossover  region  of  the  recombinant  virus.  

2.1.8

Virus  infections  

 

Cell  monolayers  (RD  or  HeLa)  were  inoculated  with  virus  at  the  stated  MOI.  Virus  was  absorbed   onto  monolayers  for  30  mins  at  37°C/5%  CO2/air.  Virus  supernatant  was  removed  and  replaced  

with  medium  supplemented  with  or  without  10%  HI-­‐FBS.  For  passaging,  virus  supernatant  was   removed  24  hours  post-­‐infection,  upon  completion  of  full  cytopathic  effect  (CPE;  appearance  of   cell  rounding  or  detached  cells).  

2.1.9

Disruption  of  cellular  microtubules  and  nocodazole  treatment  

 

Following  the  protocol  taken  from  Egger  &  Bienz,  2005.  To  disrupt  microtubules,  cells  were   kept  for  10  min  at  0°C.  Nocodazole  at  concentrations  of  5  mM  (Sigma)  was  added  to  prevent  re-­‐ polymerization  of  microtubules  upon  rewarming  to  37°C.  

Related documents